The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kendall Keith J since year 2005.
The trader's CIK number is 1406834.
At the time of this reporting, Kendall Keith J is the CEO and President of Aquestive Therapeutics, Inc. .
(stock ticker symbol AQST).
See this page for all insider trading activities at Aquestive Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-31||AQST||Aquestive Therapeutics, Inc.||Option Ex||329||.00||0|
|2018-11-30||AQST||Aquestive Therapeutics, Inc.||Option Ex||14,572||.00||0|
|2018-11-27||AQST||Aquestive Therapeutics, Inc.||Buy||1,000||9.87||9,870|
|2018-11-21||AQST||Aquestive Therapeutics, Inc.||Buy||6,000||10.17||61,020|
|2018-11-23||AQST||Aquestive Therapeutics, Inc.||Buy||1,950||9.90||19,305|
|2018-09-30||AQST||Aquestive Therapeutics, Inc.||Option Ex||329||.00||0|
|2018-08-31||AQST||Aquestive Therapeutics, Inc.||Option Ex||14,572||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kendall Keith J (CEO and President of Aquestive Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.